These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 16326126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR, Saxena AK, Al-Ghamdi AM.
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [Abstract] [Full Text] [Related]

  • 13. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors.
    Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, Usluer G, Colak E.
    Saudi Med J; 2006 May; 27(5):608-12. PubMed ID: 16680246
    [Abstract] [Full Text] [Related]

  • 14. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH, Su LH, Tang YF, Liu JW.
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
    Sekowska A, Janicka G, Kłyszejko C, Wojda M, Wróblewski M, Szymankiewicz M.
    Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G.
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.